MYGN EBITDA Margin
Myriad Genetics Inc · EBITDA Margin
MYGN EBITDA Margin
Latest reported-5.60%period ending
MYGN TTM EBITDA Margin (-81.82% → -5.60%)
TTM ebitda margin
High-resolution chart · PNG
MYGN ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -5.6038% | |
| -40.3136% | |
| -40.1334% | |
| -43.9355% | |
| -42.9343% | |
| -7.6868% | |
| -7.0917% | |
| -6.3259% | |
| -11.643% | |
| -22.5265% | |
| -26.2082% | |
| -29.7658% | |
| -29.017% | |
| -15.1% | |
| -12.4853% | |
| -11.6269% | |
| 1.2643% | |
| 4.1032% | |
| 1.7811% | |
| 11.3439% | |
| -3.5651% | |
| -17.2296% | |
| -38.171% | |
| -27.1799% | |
| -22.0013% | |
| -11.6851% | |
| 5.7536% | |
| 7.4841% | |
| 9.9871% | |
| 11.7265% | |
| 12.4702% | |
| 12.2104% | |
| 22.8011% | |
| 23.5639% | |
| 22.5625% | |
| 23.3726% | |
| 12.6005% | |
| 14.0235% | |
| 17.7653% | |
| 21.078% | |
| 25.7131% | |
| 25.6621% | |
| 25.0185% | |
| 24.0326% | |
| 22.0042% | |
| 24.2507% | |
| 26.4522% | |
| 31.5475% | |
| 37.0415% | |
| 38.9817% | |
| 40.5612% | |
| 39.7796% | |
| 38.6342% | |
| 38.1695% | |
| 37.8927% | |
| 37.8739% | |
| 38.1827% | |
| 38.99% | |
| 40.3238% | |
| 40.7124% | |
| 41.0355% | |
| 41.3662% | |
| 40.3463% | |
| 40.0708% | |
| 39.2% | |
| 50.971% | |
| 52.3769% | |
| 53.5721% | |
| 50.5651% | |
| 38.291% | |
| 29.5619% | |
| 20.0391% | |
| 14.0458% | |
| -15.0152% | |
| -17.486% | |
| -7.9814% | |
| -11.1026% | |
| -13.4778% | |
| -16.9524% | |
| -35.5041% | |
| -33.8937% | |
| -31.1503% | |
| -33.1986% | |
| -37.3648% | |
| -42.0503% | |
| -51.7217% | |
| -57.4497% | |
| -62.4116% | |
| -65.0844% | |
| -58.963% | |
| -48.4466% | |
| -41.6817% | |
| -34.3133% | |
| -34.9906% | |
| -34.1141% | |
| -30.2978% | |
| -26.3083% | |
| -20.5321% | |
| -19.2504% | |
| -18.9148% |